EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Optomed's Enterprise Value is €113.27 Mil.
Optomed's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €-3.50 Mil. Therefore, Optomed's EV-to-EBIT for today is -32.35.
The historical rank and industry rank for Optomed's EV-to-EBIT or its related term are showing as below:
OHEL:OPTOMED'
s EV-to-EBIT Range Over the Past 10 Years
Min: -123.3 Med: -17.61 Max: -5.59
Current: -32.35
During the past 9 years, the highest EV-to-EBIT of Optomed was -5.59. The lowest was -123.30. And the median was -17.61.
OHEL:OPTOMED's EV-to-EBIT is ranked worse than 100% of 432
companies
in the Healthcare Providers & Services industry
Industry Median: 17.195
vs OHEL:OPTOMED: -32.35
The historical data trend for Optomed's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Optomed's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Optomed's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Optomed's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Optomed's EV-to-EBIT falls into.
Optomed's current Enterprise Value is €113.27 Mil.
Optomed's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-3.50 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Optomed (OHEL:OPTOMED) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Optomed's Enterprise Value for the quarter that ended in Mar. 2024 was €69.00 Mil.
Optomed's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-3.50 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Optomed EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of Optomed's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Optomed PLC is a Finnish health technology company and providers of handheld camera solutions. The company operates in two business segments that are Devices and Software. Devices segment develops, commercializes and manufactures easy-to-use and affordable handheld fundus cameras, that are suitable for any clinic for screening of various eye diseases, such as diabetic retinopathy, glaucoma and AMD. The Software segment develops and commercializes screening software for diabetic retinopathy and cancer screening for healthcare organizations. The company operates in Finland, China, and other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OHEL:OPTOMED has been successfully added to your 